Chromatin modifiers in neurodevelopment.

Area of Science:

• Molecular Biology
• Neuroscience
• Genetics

Background:

• Emerging sequencing studies reveal the critical role of chromatin regulatory mechanisms in human diseases, especially neurodevelopmental and neurological disorders.
• Research highlights the intricate involvement of chromatin regulators in neurodevelopment, prompting questions about how mutations in these proteins cause nervous system dysfunction.

Purpose of the Study:

• To critically evaluate the current understanding of chromatin modifiers, focusing on methylation.
• To spotlight their pivotal roles in early brain development and neurological disorders.
• To inspire progress toward innovative treatments for challenging neurological conditions.

Main Methods:

• Mini-review of existing literature on chromatin modifiers.
• Focus on key modifiers: histone methyl transferases NSD1 and ASH1L, methyl-CpG-binding repressor MeCP2, and enzymatic repressor EZH2.
• Evaluation of methylation's role in neurodevelopment and neurological disorders.

Main Results:

• While functions of some chromatin modifiers (NSD1, ASH1L, MeCP2, EZH2) are relatively well-studied, many others in neurodevelopment remain poorly understood.
• Existing therapies targeting chromatin modifiers show promise, with some achieving clinical success.
• Neurological dysfunctions may be treatable later in life, emphasizing the therapeutic potential of chromatin modifiers.

Conclusions:

• Chromatin modifiers play pivotal roles in early brain development and neurological disorders.
• Prioritizing chromatin modifiers as therapeutic targets is urgent for developing innovative treatments.
• Further research into less understood chromatin modifiers is needed to advance treatment strategies.